Note: Ingredients listed on restricted chemical lists
EC/CAS
265-150-3/64742-48-9
Name of the chemical
Naphtha (petroleum), hydrotreated heavy
Concentration
≥50-≤75
EC/CAS
259-627-5/55406-53-6
Name of the chemical
3-Iodo-2-propynylbutylcarbamate
Concentration
≤0.47
General Information
Revision date
2026-06-01
Product name
PREMIUM TEAK OIL 6151-00 - All variants
1.2.1 Relevant identified uses
Paint
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H412
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
H304 - May be fatal if swallowed and enters airways. H412 - Harmful to aquatic life with long lasting effects.
Prevention
P273 - Avoid release to the environment.
Response
P301 + P310 + P331 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. Do NOT induce vomiting.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Contains
Naphtha (petroleum), hydrotreated heavy and Hydrocarbons, C10, aromatics, <1% naphthalene 3-iodo-2-propynyl-butyl carbamate. May produce an allergic reaction
Supplemental label elements
Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Asp. Tox. 1, H304 Aquatic Chronic 3, H412 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
